RRMS: Disease PROgression and Myeloid Profiling After Bone Marrow TRANSPLANTation and Second Line Therapies
RecruitingOBSERVATIONAL
Enrollment
30
Participants
Timeline
Start Date
September 2, 2022
Primary Completion Date
September 2, 2027
Study Completion Date
September 2, 2027
Conditions
Multiple Sclerosis
Trial Locations (1)
20132
RECRUITING
IRCCS San Raffaele, Milan
All Listed Sponsors
lead
IRCCS San Raffaele
OTHER
NCT06267781 - RRMS: Disease PROgression and Myeloid Profiling After Bone Marrow TRANSPLANTation and Second Line Therapies | Biotech Hunter | Biotech Hunter